MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS
                        
                            
                                申请人:Bristol-Myers Squibb Company
                            
                            
                                公开号:US20140294898A1
                            
                            
                                公开(公告)日:2014-10-02
                            
                            The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
                            本公开提供了新型大环肽,其能够抑制PD-1/PD-L1和PD-L1/CD80蛋白质/蛋白质相互作用,因此可用于改善各种疾病,包括癌症和传染性疾病。